Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Related Articles by Review for PubMed (Select 23154260)

1.

Structural vaccinology starts to deliver.

Dormitzer PR, Grandi G, Rappuoli R.

Nat Rev Microbiol. 2012 Dec;10(12):807-13. doi: 10.1038/nrmicro2893.

PMID:
23154260
2.

Structural vaccinology: a three-dimensional view for vaccine development.

Cozzi R, Scarselli M, Ferlenghi I.

Curr Top Med Chem. 2013;13(20):2629-37. Review.

PMID:
24066888
3.

Reverse vaccinology: developing vaccines in the era of genomics.

Sette A, Rappuoli R.

Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017. Review.

4.

Vaccines based on structure-based design provide protection against infectious diseases.

Thomas S, Luxon BA.

Expert Rev Vaccines. 2013 Nov;12(11):1301-11. doi: 10.1586/14760584.2013.840092. Epub 2013 Oct 4. Review.

PMID:
24090172
5.

Reverse vaccinology.

Mora M, Veggi D, Santini L, Pizza M, Rappuoli R.

Drug Discov Today. 2003 May 15;8(10):459-64. Review.

PMID:
12801798
6.

Vaccinology in the genome era.

Rinaudo CD, Telford JL, Rappuoli R, Seib KL.

J Clin Invest. 2009 Sep;119(9):2515-25. doi: 10.1172/JCI38330. Review.

7.

Reverse vaccinology: a genome-based approach for vaccine development.

Masignani V, Rappuoli R, Pizza M.

Expert Opin Biol Ther. 2002 Dec;2(8):895-905. Review.

PMID:
12517268
8.

Designing the next generation of vaccines for global public health.

Bagnoli F, Baudner B, Mishra RP, Bartolini E, Fiaschi L, Mariotti P, Nardi-Dei V, Boucher P, Rappuoli R.

OMICS. 2011 Sep;15(9):545-66. doi: 10.1089/omi.2010.0127. Epub 2011 Jun 17. Review.

PMID:
21682594
9.

Vaccinology at the beginning of the 21st century.

Wack A, Rappuoli R.

Curr Opin Immunol. 2005 Aug;17(4):411-8. Review.

PMID:
15950445
10.

Advances in structure-based vaccine design.

Kulp DW, Schief WR.

Curr Opin Virol. 2013 Jun;3(3):322-31. doi: 10.1016/j.coviro.2013.05.010. Epub 2013 Jun 25. Review.

11.

The use of genomics in microbial vaccine development.

Bambini S, Rappuoli R.

Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Review.

PMID:
19150507
12.

Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.

Schussek S, Trieu A, Doolan DL.

Biotechnol Adv. 2014 Mar-Apr;32(2):403-14. doi: 10.1016/j.biotechadv.2013.12.006. Epub 2014 Jan 2. Review.

PMID:
24389084
13.

Reverse vaccinology.

Rappuoli R.

Curr Opin Microbiol. 2000 Oct;3(5):445-50. Review.

PMID:
11050440
14.

Systems biology in vaccine design.

Six A, Bellier B, Thomas-Vaslin V, Klatzmann D.

Microb Biotechnol. 2012 Mar;5(2):295-304. doi: 10.1111/j.1751-7915.2011.00321.x. Epub 2011 Dec 21. Review.

15.

Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.

Van Regenmortel MH.

Arch Virol. 2012 Jan;157(1):1-20. doi: 10.1007/s00705-011-1145-2. Epub 2011 Oct 20. Review.

PMID:
22012269
16.

[Application of the branched multiple antigenic peptide system in the development of vaccine].

Liu XY, Zhang ZQ.

Bing Du Xue Bao. 2011 Jan;27(1):86-90. Review. Chinese. No abstract available.

PMID:
21462513
17.

Proteomics approaches towards antigen discovery and vaccine development.

Klade CS.

Curr Opin Mol Ther. 2002 Jun;4(3):216-23. Review.

PMID:
12139306
18.

Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens.

Corradin G, Villard V, Kajava AV.

Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):259-65. Review.

PMID:
18220946
19.

Salmonella-based vaccines for infectious diseases.

Kwon YM, Cox MM, Calhoun LN.

Expert Rev Vaccines. 2007 Apr;6(2):147-52. Review.

PMID:
17408365
20.

Immuno-informatics: Mining genomes for vaccine components.

De Groot AS, Sbai H, Aubin CS, McMurry J, Martin W.

Immunol Cell Biol. 2002 Jun;80(3):255-69. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk